Finding A Future For Renal Denervation With Better Controlled Trials
This article was originally published in The Gray Sheet
Executive Summary
Minimizing the variability in patient attributes and procedural techniques will be crucial to future renal denervation trials having a chance at success, experts suggested last month at the Transcatheter Cardiovascular Therapeutics conference in Washington, D.C.